 Oligopeptides
"Oligopeptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides composed of between two and twelve amino acids.
| Descriptor ID |
D009842
|
| MeSH Number(s) |
D12.644.456
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Oligopeptides".
Below are MeSH descriptors whose meaning is more specific than "Oligopeptides".
This graph shows the total number of publications written about "Oligopeptides" by people in this website by year, and whether "Oligopeptides" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 2 | 3 | | 1993 | 2 | 1 | 3 | | 1994 | 0 | 1 | 1 | | 1996 | 2 | 1 | 3 | | 1998 | 1 | 2 | 3 | | 1999 | 1 | 4 | 5 | | 2000 | 6 | 4 | 10 | | 2001 | 3 | 4 | 7 | | 2002 | 5 | 2 | 7 | | 2003 | 2 | 5 | 7 | | 2004 | 4 | 3 | 7 | | 2005 | 5 | 3 | 8 | | 2006 | 8 | 5 | 13 | | 2007 | 5 | 6 | 11 | | 2008 | 8 | 1 | 9 | | 2009 | 6 | 6 | 12 | | 2010 | 5 | 3 | 8 | | 2011 | 3 | 9 | 12 | | 2012 | 10 | 3 | 13 | | 2013 | 11 | 6 | 17 | | 2014 | 7 | 4 | 11 | | 2015 | 6 | 3 | 9 | | 2016 | 1 | 4 | 5 | | 2017 | 2 | 1 | 3 | | 2018 | 7 | 1 | 8 | | 2019 | 3 | 2 | 5 | | 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Oligopeptides" by people in Profiles.
-
Allen ME, Pennington ER, Perry JB, Dadoo S, Makrecka-Kuka M, Dambrova M, Moukdar F, Patel HD, Han X, Kidd GK, Benson EK, Raisch TB, Poelzing S, Brown DA, Shaikh SR. The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats. Commun Biol. 2020 07 17; 3(1):389.
-
Palmieri S, Rocco S, Vitagliano O, Catalano L, Cerchione C, Vincelli ID, Scopelliti A, Gentile M, Farina G, Barone M, Gagliardi A, Esposito D, Arcamone M, Amico V, Fontana R, Sementa A, Sica A, Svanera G, Pane F, Ferrara F. KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients. Ann Hematol. 2020 Dec; 99(12):2903-2909.
-
Hulin-Curtis SL, Davies JA, Nestic D, Bates EA, Baker AT, Cunliffe TG, Majhen D, Chester JD, Parker AL. Identification of folate receptor a (FRa) binding oligopeptides and their evaluation for targeted virotherapy applications. Cancer Gene Ther. 2020 11; 27(10-11):785-798.
-
Davidson MD, Ban E, Schoonen ACM, Lee MH, D'Este M, Shenoy VB, Burdick JA. Mechanochemical Adhesion and Plasticity in Multifiber Hydrogel Networks. Adv Mater. 2020 Feb; 32(8):e1905719.
-
Roda MA, Xu X, Abdalla TH, Sadik M, Szul T, Bratcher PE, Viera L, Solomon GM, Wells JM, McNicholas CM, Redegeld FA, Folkerts G, Blalock JE, Gaggar A. Proline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced Emphysema. Am J Respir Cell Mol Biol. 2019 11; 61(5):560-566.
-
Vaitaitis GM, Yussman MG, Wagner DH. A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2019 07 15; 332:8-15.
-
Forsberg PA, Rossi AC, Boyer A, Tegnestam L, Pearse RN, Perry A, Pekle KA, Jayabalan D, Ely S, Boussi L, Sherbenou DW, Williams C, Allan JN, Coleman M, Niesvizky R, Mark TM. Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. Am J Hematol. 2019 05; 94(5):539-545.
-
Crawford ED, Tombal B, Keane T, Boccardo F, Miller K, Shore N, Moul JW, Damber JE, Collette L, Persson BE. FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist. Scand J Urol. 2018 Oct - Dec; 52(5-6):349-357.
-
Fete MG, Betker JL, Shoemaker RK, Anchordoquy TJ. A novel method for conjugating the terminal amine of peptide ligands to cholesterol: synthesis iRGD-cholesterol. Ther Deliv. 2019 01; 10(1):11-20.
-
Ou Y, Xu Y, Gore L, Harvey RD, Mita A, Papadopoulos KP, Wang Z, Cutler RE, Pinchasik DE, Tsimberidou AM. Physiologically-based pharmacokinetic modelling to predict oprozomib CYP3A drug-drug interaction potential in patients with advanced malignancies. Br J Clin Pharmacol. 2019 03; 85(3):530-539.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|